Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Ventiv Health Ltd.

In 1995 Ventiv Kft. commenced its operations in the areas of pharmaceutical labor recruitment and labor outsourcing. The company initially conducted its activity under English ownership and the name RDL. Today the company is 100% Hungarian owned. The name Ventiv Group encompasses the operation of four business lines. In the form of a company group, it is the market leading Hungarian pharmaceutical HR service provider.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

Ventiv Health Ltd.
Horvat u. 14-24., Budapest, 1027, Hungary
3612140658
Contact Ventiv Health Ltd.
Website

 Latest Content from PMHub 

Multi-level Segmentation Solution

White Papers and Resources | September 6, 2017 | Inizio

Our client has an established product for multiple indications. They wanted to create a HCP segmentation typing tool which could be implemented in-field to help classify physicians across two different...

Global health care specialists from coast to coast

White Papers and Resources | September 6, 2017 | Inizio

Published in Quirk's Faces of Marketing Research August 2017

Demand assessment research video

White Papers and Resources | September 6, 2017 | Inizio

Head of Business Analytics Tom Nolte and Associate Director Will Tolley discuss demand assessment research – the various techniques and when in a product's stage of development a demand assessment...

Building a creative marketing consultancy: how we’ve transitioned into a full service global team

White Papers and Resources | September 5, 2017 | Blue Latitude Health

In this Q&A, James Atherton, Vice President and Managing Consultant at our New York office, reveals how our NYC and London offices work together and why having a creative services...

Can we ‘outsmart’ smartphone addiction by using it to develop effective health apps?

White Papers and Resources | September 4, 2017 | Say Communications

Are you guilty of repeatedly checking your phone 24/7? Our new blog explores what makes them so addictive and how understanding this may help us develop more effective health apps.

Lucid welcome their graduate Customer Experience Managers

Press Releases | September 4, 2017 | Lucid Group Communications Limited

Lucid has had an incredibly busy summer attending recruitment fairs all across the country to find the finest graduate talent for their Futures Executive Programme. As part of its graduate...

The science of experience planning in pharma media

White Papers and Resources | September 1, 2017 | Four Agency Worldwide

Our digital lead, Richard Springham, looks at how the principles of behavioural science and experience planning are used in best practice pharma media planning.

Who will be the new disrupter of HCP media

White Papers and Resources | September 1, 2017 | Four Agency Worldwide

Our digital lead, Richard Springham, looks at the move of the tech behemoths and the impact on HCP media.

Why I think rare disease companies are more patient-centric

White Papers and Resources | September 1, 2017 | Say Communications

Guest blogger Kamlesh Sheth believes companies that specialise in rare disease tend to be more patient-centric.

“Legal highs” ruling leaves illegal labs laughing

White Papers and Resources | August 31, 2017 | Life Healthcare Communications

In a test case yesterday, a judge said yes to NO